Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Assessment of LBR-101 In Chronic Migraine [Phase 2]
Phase 2 clinical trial assessing LBR-101 in chronic migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients [Phase 3]
Phase 3 safety evaluation trial of TEV-48125 self-administered for migraine completed.
-
FDA approval · 2021-10-18FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)
FDA approved the original application for butalbital, aspirin, and caffeine (Butalbital, Aspirin, and Caffeine) submitted by LGM Pharma Solu…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Sphenopalatine Ganglion Blocks RCT [Phase 4]
A Phase 4 randomized controlled trial evaluating sphenopalatine ganglion blocks for migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine [Phase 2]
A Phase 2 trial evaluating valproic acid with dihydroergotamine as abortive therapy in children with migraine was terminated; results were l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-30FDA Approved: ZOLMITRIPTAN — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for zolmitriptan from Padagis Israel Pharmaceuticals Ltd, marking a new generic entry for acute treatm…
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
FDA approval · 2021-09-28FDA Approved: QULIPTA — Original Application (AbbVie Inc.)
The FDA approved QULIPTA (atogepant) from AbbVie in its original NDA for the preventive treatment of migraine in adults.
-
FDA approval · 2021-09-24FDA Approved: VYEPTI — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for VYEPTI (eptinezumab-jjmr) submitted by Lundbeck Pharmaceuticals LLC. The action concerns the use…
-
FDA approval · 2021-09-24FDA Approved: AJOVY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for AJOVY (fremanezumab-vfrm) from Teva Pharmaceuticals USA, Inc. This action updates the product's …
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Greater Occipital Nerve Block Versus Metoclopramide [Phase 4]
Phase 4 trial comparing Greater Occipital Nerve Block to Metoclopramide for migraine; completed with posted results.
-
FDA approval · 2021-09-02FDA Approved: TRUDHESA — Original Application (Impel Pharmaceuticals LLC)
FDA approved TRUDHESA (dihydroergotamine mesylate) from Impel Pharmaceuticals as an original NDA submission for acute treatment of migraine.…
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Migraine Prophylaxis With Clopidogrel Trial [Phase 4]
Phase 4 clinical trial update exploring migraine prophylaxis with clopidogrel; current status unknown.
-
FDA approval · 2021-08-26FDA Approved: TOPIRAMATE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' generic version of topiramate through an original ANDA.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine [Phase 3]
Phase 3 study evaluating intravenous eptinezumab for acute migraine attacks has completed with posted results.
-
FDA approval · 2021-08-13FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Amici Pharma, Inc.)
The FDA approved Amici Pharma's generic Butalbital, Acetaminophen and Caffeine under an original ANDA, providing a generic option for analge…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine [Phase 4]
Phase 4 head-to-head trial comparing erenumab to topiramate in episodic and chronic migraine completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults [Phase 2, Phase 3]
Pfizer completed Phase 2 and Phase 3 trials evaluating rimegepant for migraine prevention in adults, with results posted in August 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine [Phase 3]
Phase 3 trial update on long-term safety and tolerability of subcutaneous TEV-48125 for preventive treatment of migraine completed; results …
-
FDA approval · 2021-07-13FDA Approved: SUMATRIPTAN — Original Application (Somerset Therapeutics, LLC)
FDA approves the original application for Sumatriptan from Somerset Therapeutics, LLC, granting a generic version of the acute treatment for…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine [Phase 2, Phase 3]
Clinical trial update reports efficacy and safety data for subcutaneous TEV-48125 used preventively in episodic migraine, spanning Phase 2 a…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of Lasmiditan (LY573144) Over Four Migraine Attacks [Phase 3]
Phase 3 trial update on lasmiditan (LY573144) across four migraine attacks with completed results posted.
-
FDA approval · 2021-07-01FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Sumatriptan Succinate from Mylan Pharmaceuticals Inc.
-
FDA label_change · 2021-06-30FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) submitted by Janssen Pharmaceuticals; the snippet does not specify the exac…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine [Phase 2, Phase 3]
Phase 2/3 trial update on subcutaneous TEV-48125 for preventive treatment of migraine, with completed status and posted results.